Abstract 1470: Development & characterization of a new oncolytic immunotherapy platform based on herpes simplex virus type 1

MLA

Robert S. Coffin, et al. “Abstract 1470: Development & Characterization of a New Oncolytic Immunotherapy Platform Based on Herpes Simplex Virus Type 1.” Cancer Research, vol. 79, July 2019, p. 1470. EBSCOhost, https://doi.org/10.1158/1538-7445.am2019-1470.

APA

Robert S. Coffin, Joan N. Kyula, Howard L. Kaufman, Victoria Roulstone, Linta Juncheria, Suzanne Thomas, & Kevin J. Harrington. (2019). Abstract 1470: Development & characterization of a new oncolytic immunotherapy platform based on herpes simplex virus type 1. Cancer Research, 79, 1470. https://doi.org/10.1158/1538-7445.am2019-1470

Chicago

Robert S. Coffin, Joan N. Kyula, Howard L. Kaufman, Victoria Roulstone, Linta Juncheria, Suzanne Thomas, and Kevin J. Harrington. 2019. “Abstract 1470: Development & Characterization of a New Oncolytic Immunotherapy Platform Based on Herpes Simplex Virus Type 1.” Cancer Research 79 (July): 1470. doi:10.1158/1538-7445.am2019-1470.